Mavik 0.5mg. 2mg Hard capsules.
PDF Leaflet Revision Date: 27 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension.
Dosage (summary)
Initial: 0.5 mg daily; Maintenance: 2 mg daily (max 4 mg).
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly patients
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; safety in lactation not established.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Fluoroquinolones
Contraindications
- Hypersensitivity to trandolapril
- History of angioedema
- Severe renal impairment
- Pregnancy
- Concomitant use of aliskiren
Common side effects
- Cough
- Dizziness
- Hypotension
- Hyperkalaemia
Counselling Points
- Monitor blood pressure regularly.
- Avoid potassium supplements.
- Report any signs of angioedema immediately.
Serious warnings
- Risk of symptomatic hypotension
- Agranulocytosis
- Angioedema
Important Disclaimer
The Mavik 0.5mg. 2mg Hard capsules. professional information leaflet below is the property of Abbott Laboratories Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
